Exian Mou
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Beyond estrobolome 1.0: unraveling endocrine-microbiome axis as a driver and therapeutic target in hormone-driven cancers.
Journal: NPJ biofilms and microbiomes
Published: March 10, 2026
Risk factors for complications after reduction mammaplasty: a systematic review and meta-analysis.
Journal: European journal of medical research
Published: December 01, 2024
Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy.
Journal: Scientific reports
Published: July 22, 2024
The optimal neoadjuvant treatment strategy for HR+/HER2 + breast cancer: a network meta-analysis.
Journal: Scientific reports
Published: July 19, 2024
A retrospective comparative cohort study of SEER database analysis of the prognostic value of breast-conserving surgery and mastectomy in patients with multifocal multicenter breast cancer.
Journal: Gland surgery
Published: November 02, 2022
Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence.
Journal: Journal of oncology
Published: September 23, 2021
miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway.
Journal: Oncology letters
Published: August 21, 2021
Enhancing social support and knowledge perception decreases patient delay in breast cancer.
Journal: Gland surgery
Published: March 04, 2021
Therapeutic Effect of Trastuzumab in Neoadjuvant-Treated HER2-Positive Breast Cancer with Low Infiltrating Level of Tumor-Infiltrating Lymphocytes.
Journal: Cancer management and research
Published: February 02, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026